Practicalities of a reduced volume formulation of a C1-INH concentrate for the treatment of hereditary angioedema: real-life experience
Abstract Background Hereditary angioedema (HAE) due to C1 esterase inhibitor (C1-INH) deficiency is characterized by recurrent swelling attacks that can be life-threatening if left untreated. Prompt treatment is vital during acute attacks; plasma-derived C1-INH (Berinert®) is one treatment currently...
Main Author: | John Dempster |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13223-018-0267-4 |
Similar Items
-
Diagnosis and screening of patients with hereditary angioedema in primary care
by: Henao MP, et al.
Published: (2016-05-01) -
Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
by: Andrea Zanichelli, et al.
Published: (2018-10-01) -
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
by: Stefan Hintze, et al.
Published: (2023-01-01) -
Overview of SERPING1 Variations Identified in Hungarian Patients With Hereditary Angioedema
by: Edina Szabó, et al.
Published: (2022-03-01) -
The Genetics of Hereditary Angioedema: A Review
by: Rosa Santacroce, et al.
Published: (2021-05-01)